Ultrasonographic Evaluation of Talar Cartilage Thickness in Patients With Spinal Cord Injury (NCT07293949) | Clinical Trial Compass
CompletedNot Applicable
Ultrasonographic Evaluation of Talar Cartilage Thickness in Patients With Spinal Cord Injury
Turkey (Türkiye)76 participantsStarted 2025-12-20
Plain-language summary
Spinal cord injury patients often present with musculoskeletal comorbidities, including osteoarthritis. Early detection of cartilage damage is important for preventing osteoarthritis progression. This study aims to compare the talar cartilage thicknesses of spinal cord injury patients with healthy subjects. The secondary aim is to investigate a correlation between the talar cartilage thickness and disease-related parameters. The patient group is to be assessed for talar cartilage thickness (via ultrasound), functional status, spasticity, and ambulation levels.
Who can participate
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Aged between 18 to 60 years,
* Cervical, thoracal or lumber level of spinal cord injury
* AIS (American Spinal Injury Association Impairment Scale) Level A, B, C, or D
* Assisted ambulation of any kind
* Literacy
* Giving oral and written consent to participate in the study
Exclusion Criteria:
* Patients with sacral level injury
* AIS E
* MAS 4 level of spasticity
* History of any lower extremity operation
* History of fracture
* Botulinum toxin injection in the last 6 months
* Existing diagnosis of any rheumatologic or endocrine diseases
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Talar cartilage thickness
Timeframe: Baseline
Trial details
NCT IDNCT07293949
SponsorGaziosmanpasa Research and Education Hospital